One might cite Bausch Health acquiring Dendreon,
Post# of 148091
The main point to make is that Leron is a unicorn, and you like the rest of it know it. No OTC has ever owned a platform drug that might very well be of use in 90+ indications.
So no comparison can be made, which makes your point moot.